Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome
- PMID: 9307633
- DOI: 10.1016/s0161-6420(97)30124-9
Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome
Abstract
Purpose: Carbomer gel is a water-soluble polymeric resin that has been reported to maintain the tear film in contact with the eye for an extended period. The efficacy and safety of this new artificial tear were assessed.
Methods: A multicenter, single-masked, randomized, placebo-controlled study was carried out on 123 patients with moderate-to-severe dry eyes. The placebo was a mannitol solution with benzalkonium chloride 0.008% as preservative. Patients were observed over an 8-week period, and subjective and objective changes analyzed, compared to a baseline of no therapy, after 1 to 7 days washout period from previous medication.
Results: All primary subjective symptoms decreased significantly in the carbomer gel-treated group compared to the placebo group (i.e., dryness, discomfort, and foreign body sensation). The carbomer gel also significantly improved the rose bengal staining score relative to placebo. When data for the primary subjective efficacy variables were stratified for disease severity, there was a statistically significant improvement from baseline by day 10 for severely affected patients and from day 42 for patients with moderate disease. Secondary subjective symptoms that improved significantly in the tear gel group compared to placebo were photophobia, erythema, tear breakup time, blurry-filmy, dry-sandy sensation, and physician impression. However, no significant improvements in the secondary subjective symptoms of tearing, itching, scaling, conjuctival discharge, palpebral conjunctival redness, bulbar conjuctival redness, conjunctival luster, relief of discomfort, ease of use, and overall acceptability were found in either group over the baseline score. In addition, neither carbomer gel nor placebo improved the baseline fluorescein staining score or the Schirmer test score. Two patients suffered local allergic reactions to the carbomer gel or its preservative, which settled on withdrawal of the medication.
Conclusions: Carbomer gel was more efficacious than was placebo in improving a number of subjective and objective symptoms of moderate-to-severe dry eye syndrome. The results of this study indicate that carbomer gel was a safe as was the placebo.
Similar articles
-
Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears.Eye (Lond). 1998;12 ( Pt 5):839-47. doi: 10.1038/eye.1998.215. Eye (Lond). 1998. PMID: 10070521 Clinical Trial.
-
Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.Clin Ther. 2010 Jan;32(1):44-52. doi: 10.1016/j.clinthera.2010.01.024. Clin Ther. 2010. PMID: 20171410 Clinical Trial.
-
A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes.J Huazhong Univ Sci Technolog Med Sci. 2008 Oct;28(5):592-5. doi: 10.1007/s11596-008-0523-9. Epub 2008 Oct 10. J Huazhong Univ Sci Technolog Med Sci. 2008. PMID: 18846346 Clinical Trial.
-
A review of the efficacy, safety and tolerability of Lacrycon® eye drops for the treatment of dry eye syndrome.J Fr Ophtalmol. 2019 Jun;42(6):642-654. doi: 10.1016/j.jfo.2018.08.008. Epub 2019 Mar 28. J Fr Ophtalmol. 2019. PMID: 30929965
-
Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review.Arq Bras Oftalmol. 2019 Sep 9;82(5):436-445. doi: 10.5935/0004-2749.20190097. Arq Bras Oftalmol. 2019. PMID: 31508669
Cited by
-
Over the counter (OTC) artificial tear drops for dry eye syndrome.Cochrane Database Syst Rev. 2016 Feb 23;2(2):CD009729. doi: 10.1002/14651858.CD009729.pub2. Cochrane Database Syst Rev. 2016. PMID: 26905373 Free PMC article.
-
Post-LASIK dry eye disease: A comprehensive review of management and current treatment options.Front Med (Lausanne). 2023 Apr 11;10:1057685. doi: 10.3389/fmed.2023.1057685. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37113611 Free PMC article. Review.
-
Overview of 37 Tear Substitutes in Europe Based on Various Physicochemical Parameters.Ophthalmol Ther. 2024 Oct;13(10):2799-2812. doi: 10.1007/s40123-024-01023-9. Epub 2024 Sep 3. Ophthalmol Ther. 2024. PMID: 39225713 Free PMC article.
-
The protective effect of vitamin A palmitate eye gel on the ocular surface during general anaesthesia surgery: a randomized controlled trial.Int Ophthalmol. 2024 Apr 4;44(1):168. doi: 10.1007/s10792-024-03074-0. Int Ophthalmol. 2024. PMID: 38573375 Free PMC article. Clinical Trial.
-
Active agents, biomaterials, and technologies to improve biolubrication and strengthen soft tissues.Biomaterials. 2018 Oct;181:210-226. doi: 10.1016/j.biomaterials.2018.07.040. Epub 2018 Jul 26. Biomaterials. 2018. PMID: 30092370 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources